Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?

Oncotarget(2023)10.18632/oncotarget.28438Source: DataRank Database

Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer? is a research paper published in Oncotarget (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.17)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Xiaosong Wang ORCID,Chia-Chia Liu

Live enrichment

PubMed:37306551 PMC:PMC10259257 OpenAlex:https://openalex.org/W4380290920

NCI NIH HHS

Grant: R01 CA183976

NCI NIH HHS

Grant: R21 CA237964

NCI NIH HHS

Grant: R01 CA181368

National Institutes of Health

Grant: 5R01CA183976-02

CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER

National Institutes of Health

Grant: 1R21CA237964-01A1

Characterization of EPHA3 intragenic rearrangements in high-grade serous carcinoma progression and recurrence

National Institutes of Health

Grant: 5R01CA181368-02

Integrative Consig: NLK as Attractive Drug Target for Intractable Breast Cancer

FWCI

0.17

Citation Percentile

0.5%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.18632/oncotarget.28438

publisherhttps://doi.org/10.18632/oncotarget.28438

publisherhttps://www.oncotarget.com/lookup/doi/10.18632/oncotarget.28438

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37306551

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10259257

Fields of Study

Lung Cancer Treatments and MutationsCancer-related Molecular PathwaysGenetic factors in colorectal cancer03 medical and health sciences0302 clinical medicine

MeSH Terms

BreastBreast NeoplasmsFemaleHumans

Keywords

PathologicalMedicineBreast cancerCancer researchCancerFusion proteinOncologyPathologyBioinformaticsInternal medicineBiologyGeneGeneticsMek InhibitorLuminal B Breast CancerRad51ap1-dyrk4Chimerical TranscriptEditorialHumansFemaleBreast NeoplasmsBreast

Sustainable Development Goals

SDG 0: Good health and well-being